EFFECT OF A CO-STIMULATORY ENDODOMAIN ON THE PERFORMANCE OF T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AT CD19 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES

被引：1
|
作者：
Ramos, C. A. [1 ]
Savoldo, B. [1 ]
Liu, E. [1 ]
Bollard, C. M. [1 ]
Carrum, G. [1 ]
Kamble, R. T. [1 ]
Mims, M. P. [1 ]
Keating, M. [2 ]
Gee, A. P. [1 ]
Mei, Z. [1 ]
Rooney, C. M. [1 ]
Heslop, H. E. [1 ]
Brenner, M. K. [1 ]
Dotti, G. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.186
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
163
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [1] Effect of a costimulatory endodomain on the performance of T cells expressing CD19-directed chimeric antigen receptors (CARs) in subjects with relapsed/refractory B-cell malignancies
    Ramos, C. A.
    Savoldo, B.
    Liu, E.
    Bollard, C. M.
    Mims, M. P.
    Keating, M. J.
    Gee, A. P.
    Mei, Z.
    Rooney, C. M.
    Heslop, H. E.
    Brenner, M. K.
    Dotti, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Iqbal, Madiha
    Jagadeesh, Deepa
    Chavez, Julio
    Khurana, Arushi
    Rosenthal, Allison
    Craver, Emily
    Epperla, Narendranath
    Li, Zhuo
    Isufi, Iris
    Awan, Farrukh T.
    Dholaria, Bhagirathbhai R.
    Maakaron, Joseph E.
    Sandoval-Sus, Jose D.
    Mishra, Rahul
    Saha, Aditi
    Annunzio, Kaitlin
    Bhaskar, Shakthi T.
    Sumransub, Nuttavut
    Fijalka, Andrew
    Ivanov, Stanislav A.
    Lin, Yi
    Kharfan-Dabaja, Mohamed A.
    BONE MARROW TRANSPLANTATION, 2024, 59 (02) : 211 - 216
  • [3] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Madiha Iqbal
    Deepa Jagadeesh
    Julio Chavez
    Arushi Khurana
    Allison Rosenthal
    Emily Craver
    Narendranath Epperla
    Zhuo Li
    Iris Isufi
    Farrukh T. Awan
    Bhagirathbhai R. Dholaria
    Joseph E. Maakaron
    Jose D. Sandoval-Sus
    Rahul Mishra
    Aditi Saha
    Kaitlin Annunzio
    Shakthi T. Bhaskar
    Nuttavut Sumransub
    Andrew Fijalka
    Stanislav A. Ivanov
    Yi Lin
    Mohamed A. Kharfan-Dabaja
    Bone Marrow Transplantation, 2024, 59 : 211 - 216
  • [4] The Effects of Co-Stimulatory Endodomains on the Fate of T Cells Expressing a Tumor Directed Chimeric Antigen Receptor (CAR) In Human Subjects with B Cell Malignancies
    Savoldo, Barbara
    Ramos, Carlos A.
    Bollard, Catherine M.
    Liu, Enli
    Mims, Martha
    Keating, Michael
    Gee, Adrian P.
    Mei, Zhuyong
    Robney, Cliona M.
    Heslop, Helen E.
    Brenner, Malcolm K.
    Dotti, Gianpietro
    BLOOD, 2010, 116 (21) : 1610 - 1611
  • [5] Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
    Ying, Zhitao
    He, Ting
    Wang, Xiaopei
    Zheng, Wen
    Lin, Ningjing
    Tu, Meifeng
    Xie, Yan
    Ping, Lingyan
    Zhang, Chen
    Liu, Weiping
    Deng, Lijuan
    Wu, Meng
    Feng, Feier
    Leng, Xin
    Du, Tingting
    Qi, Feifei
    Hu, Xuelian
    Ding, Yanping
    Lu, Xin-an
    Song, Yuqin
    Zhu, Jun
    BMC CANCER, 2021, 21 (01)
  • [6] Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
    Zhitao Ying
    Ting He
    Xiaopei Wang
    Wen Zheng
    Ningjing Lin
    Meifeng Tu
    Yan Xie
    Lingyan Ping
    Chen Zhang
    Weiping Liu
    Lijuan Deng
    Meng Wu
    Feier Feng
    Xin Leng
    Tingting Du
    Feifei Qi
    Xuelian Hu
    Yanping Ding
    Xin-an Lu
    Yuqin Song
    Jun Zhu
    BMC Cancer, 21
  • [7] Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
    Hay, Kevin A.
    Turtle, Cameron J.
    DRUGS, 2017, 77 (03) : 237 - 245
  • [8] Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
    Kevin A. Hay
    Cameron J. Turtle
    Drugs, 2017, 77 : 237 - 245
  • [9] Chimeric antigen receptor-modified T cells directed against CD19 in patients with relapsed or refractory CD19-positive B-cell lymphomas: interim analysis of a phase 1 study
    Ying, Zhitao
    Xiang, Xiaoyu
    Song, Yuqin
    Ding, Ning
    Lin, Yufu
    Zheng, Wen
    Wang, Xiaopei
    Lin, Ningjing
    Tu, Meifeng
    Xie, Yan
    Zhang, Chen
    Liu, Weiping
    Deng, Lijuan
    Liu, Yanling
    Yue, Yunqiang
    Yu, Xueyun
    Liu, Hanzhi
    Duan, Panpan
    Mamuti, Mierzhati
    Guo, Xiaokai
    Chen, Feng
    Wu, Xiaoyan
    Zhang, Junqing
    Zhang, Tingting
    Huang, Xue F.
    Jones, Lindsey
    Kang, Xi
    Chen, Si-Yi
    Zhu, Jun
    LANCET ONCOLOGY, 2017, 18 : S9 - S9
  • [10] CD19 Chimeric Antigen Receptor Therapy for Refractory Aggressive B-Cell Lymphoma
    Jacobson, Caron A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) : 328 - +
12345